These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15250064)

  • 21. [To increase bone density faster and stronger].
    MMW Fortschr Med; 2005 May; 147(18):44-5. PubMed ID: 15934589
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.
    Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Marques-Neto JF; Weryha G; Verbruggen N; Hustad CM; Mahlis EM; Melton ME
    Int J Clin Pract; 2008 Apr; 62(4):575-84. PubMed ID: 18324951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alendronate.
    Hamdy RC
    South Med J; 1999 Nov; 92(11):1118-20. PubMed ID: 10586845
    [No Abstract]   [Full Text] [Related]  

  • 24. [FACT study: benefits of alendronate].
    MMW Fortschr Med; 2005 Jan; 147(1-2):52-3. PubMed ID: 15704574
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An advantage for compliance: alendronate once weekly].
    MMW Fortschr Med; 2005 Dec; 147(49-50):75. PubMed ID: 16401017
    [No Abstract]   [Full Text] [Related]  

  • 27. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of alendronate after 5 years of treatment.
    Delmas PD
    JAMA; 2007 May; 297(18):1979-80; author reply 1980-1. PubMed ID: 17488957
    [No Abstract]   [Full Text] [Related]  

  • 30. Benefit period using alendronate to increase bone mineral density in women with osteoporosis?
    Ozdemir F; Rodoplu M
    Chin Med J (Engl); 2005 Mar; 118(5):383-90. PubMed ID: 15780207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of alendronate after 5 years of treatment.
    Erviti J; Gorricho J
    JAMA; 2007 May; 297(18):1979; author reply 1980-1. PubMed ID: 17488959
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of alendronate after 5 years of treatment.
    Ott SM
    JAMA; 2007 May; 297(18):1979; author reply 1980-1. PubMed ID: 17488958
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
    Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of alendronate in postmenopausal women with osteoporosis.
    Yaniv I
    Osteoporos Int; 2003 Jan; 14(1):90-1. PubMed ID: 12577190
    [No Abstract]   [Full Text] [Related]  

  • 36. [Modern osteoporosis therapy. Only once weekly against osteoporosis].
    MMW Fortschr Med; 2001 Jul; 143(28-29):52-3. PubMed ID: 11499150
    [No Abstract]   [Full Text] [Related]  

  • 37. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
    Gold DT; Martin BC; Frytak JR; Amonkar MM; Cosman F
    Curr Med Res Opin; 2007 Mar; 23(3):585-94. PubMed ID: 17355739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing.
    Colón-Emeric CS
    JAMA; 2006 Dec; 296(24):2968-9. PubMed ID: 17190899
    [No Abstract]   [Full Text] [Related]  

  • 39. By the way, doctor. I recently heard that I can take Fosamax once a week for osteoporosis, rather than every day. Is it really effective when taken this way? Is there a downside?
    Robb-Nicholson C
    Harv Womens Health Watch; 2001 May; 8(9):8. PubMed ID: 11410457
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
    Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.